SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-19-047927
Filing Date
2019-08-29
Accepted
2019-08-29 13:56:51
Documents
1
Group Members
GILEAD THERAPEUTICS A1 UNLIMITED CO

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a19-17729_1sc13da.htm SC 13D/A 76893
  Complete submission text file 0001104659-19-047927.txt   78404
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address GEN DE WITTELAAN L11 A3 2800 MECHELEN C9 00000
Business Address GEN DE WITTELAAN L11 A3 2800 MECHELEN C9 00000 3215342900
GALAPAGOS NV (Subject) CIK: 0001421876 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A | Act: 34 | File No.: 005-88880 | Film No.: 191065489
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences